NCT02311270已完成不适用
Survey on Cardiovascular Events in Patients With Metabolic Disease on Chronic Carnitine Supplementation
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 106
- 试验地点
- 1
- 主要终点
- Assess how many patients with metabolic disorders are on chronic carnitine supplementation.
研究概览
简要总结
The purpose of this study is to learn about the effects of long term carnitine use in patients with metabolic disorders and its potential relationship to cardiovascular events.
详细描述
This online cross-sectional survey will examine the self-reported long-term carnitine use in patients with metabolic disorders and any potential relationship to cardiovascular events.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Cross Sectional
入排标准
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Diagnosis of mitochondrial disease or any other metabolic disorder
- •Any age group
- •NAMDC or RDCRN registry participant
排除标准
- •Inability to provide informed consent and complete survey
- •Lack of participation in NAMDC or RDCRN registry
结局指标
主要结局
Assess how many patients with metabolic disorders are on chronic carnitine supplementation.
时间窗: Up to one year from study activation.
次要结局
- Assess how many patients who are on chronic carnitine supplementation have experienced a cardiovascular event.(Up to one year from study activation)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
4 期
Effects of L-carnitine Therapy on the Heart of Maintenance Hemodialysis PatientsRenal DialysisNCT05673239The First Affiliated Hospital of Zhejiang Chinese Medical University1,008
进行中（未招募）
2 期
Effect of L-Carnitine on Biomarkers of Myocardial Reperfusion Injury in Patients With STEMIReperfusion Injury, MyocardialMyocardial InfarctionNCT06564909Ain Shams University76
招募中
不适用
Cardiovascular Disease in Patients With Chronic Kidney Disease: Polish Kidney- Heart ProjectCardiovascular DiseasesChronic Kidney DiseaseNCT06083168Medical University of Silesia6,000
进行中（未招募）
不适用
Effects of L-carnitine administration in patients with elevated Lp(a)levels. - NDDislipidemic patients with Lp(a)>35 mg/dlLDL-C<190 mg/dl, TG<500 mg/dlMedDRA version: 9.1Level: LLTClassification code 10062060EUCTR2010-022041-19-ITRostaQuo S.p.A.
已完成
不适用
The Effect of Oral Carnitine Supplementation on MRS-derived Mitochondrial FunctionElderlyPre-diabeticNCT02124590Duke University14